Ceevra Overview

  • Founded
  • 2016

Founded
  • Status
  • Private

  • Employees
  • 12

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

  • Investors
  • 19

Ceevra General Information

Description

Developer of advanced visualization technology designed to convert a patient's existing CT or MR image into an interactive digital 3D model. The company's technology generates 3D models to help surgeons educate and counsel patients to decide on the surgical approach and gain important insights while operating on a patient, enabling surgeons to educate and connect with their patients over video.

Contact Information

Website
www.ceevra.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Primary Office
  • 149 New Montgomery Street
  • 4th Floor
  • San Francisco, CA 94105
  • United States
+1 (415) 000-0000

Ceevra Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ceevra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 01-Jun-2021 $10M 000.00 Completed Generating Revenue
5. Seed Round 01-Apr-2020 00000 00.000 00.000 Completed Generating Revenue
4. Seed Round 30-Aug-2019 00000 00.00 00.00 Completed Generating Revenue
3. Seed Round 30-Jun-2018 00000 00.00 00.00 Completed Generating Revenue
2. Seed Round 26-Dec-2017 $650K $1.2M 00.000 Completed Generating Revenue
1. Seed Round 31-Mar-2017 $550K $550K 00.000 Completed Generating Revenue
To view Ceevra’s complete valuation and funding history, request access »

Ceevra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 1D 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 1C 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed 1B 1,567,917 $0.000100 $0.47 $0.47 1x $0.47 13.78%
Seed 1A 2,774,761 $0.000100 $0.24 $0.24 1x $0.24 24.39%
To view Ceevra’s complete cap table history, request access »

Ceevra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of advanced visualization technology designed to convert a patient's existing CT or MR image into an interacti
Decision/Risk Analysis
San Francisco, CA
12 As of 2022
000.00
00000000000 000.00

000000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
0000000000000 00000000
Los Angeles, CA
00 As of 0000
000.00
000000000 - 000.00

000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
00000 0000000000 0000000000 0000000
Santa Clara, CA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ceevra Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Surgical Theater Venture Capital-Backed Los Angeles, CA 00 000.00 000000000 - 000.00
000000000 Venture Capital-Backed Santa Clara, CA 00 000.00 000000000 - 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Ceevra Patents

Ceevra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210142485-A1 Image analysis system for identifying lung features Active 11-Nov-2019 00000000
EP-4058982-A1 Image analysis system for identifying lung features Pending 11-Nov-2019 00000000
US-20220237805-A1 Image analysis system for identifying lung features Pending 11-Nov-2019 00000000
US-11348250-B2 Image analysis system for identifying lung features Active 11-Nov-2019 00000000 0
EP-3833291-A4 System and method for identifying comparable cases in preoperative surgical planning Pending 08-Aug-2018 A61B34/25 0
To view Ceevra’s complete patent history, request access »

Ceevra Executive Team (4)

Name Title Board Seat Contact Info
Russ Yoshinaka JD Co-Founder, Chief Executive Officer & Board Member
Ken Koster Co-Founder and Chief Technology Officer
Joseph Shirk MD Co-Founder and Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Ceevra Board Members (1)

Name Representing Role Since
Russ Yoshinaka JD Ceevra Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Ceevra’s complete board members history, request access »

Ceevra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ceevra Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kerry Champion Angel (individual) Minority 000 0000 000000 0
Aston Motes Angel (individual) Minority 000 0000 000000 0
Ben Smith Angel (individual) Minority 000 0000 000000 0
Camille Germanos Angel (individual) Minority 000 0000 000000 0
Farzad Nazem Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »